Table 4.
Items3 | Met Source | Met Dose | CAT (U/mg-prot) | T-SOD (U/mg-prot) | GSH-Px (U/mg-prot) | T-AOC (U/mg-prot) | MDA (nmol/mg-prot) |
---|---|---|---|---|---|---|---|
1 | BD | 0 | 0.71d | 18.94e | 30.57c | 0.35 | 0.86a |
2 | dl-Met | 0.15% | 0.77c | 23.15d | 35.88bc | 0.41 | 0.70b |
3 | dl-Met | 0.30% | 0.81abc | 28.43ab | 38.34ab | 0.46 | 0.59b |
4 | dl-Met | 0.45% | 0.81abc | 26.68abcd | 37.54ab | 0.45 | 0.61b |
5 | dl-Met | 0.60% | 0.80abc | 25.77bcd | 38.01ab | 0.44 | 0.56b |
6 | dl-Met-Met | 0.15% | 0.79bc | 24.54cd | 36.18b | 0.41 | 0.64b |
7 | dl-Met-Met | 0.30% | 0.85a | 25.77a | 42.66a | 0.44 | 0.59b |
8 | dl-Met-Met | 0.45% | 0.84ab | 27.83abc | 39.38ab | 0.42 | 0.64b |
9 | dl-Met-Met | 0.60% | 0.84ab | 28.20ab | 40.51ab | 0.44 | 0.65b |
SEM | 0.009 | 0.641 | 0.765 | 0.012 | 0.021 | ||
P-values | |||||||
treatment effects | <0.001 | <0.001 | 0.008 | 0.604 | 0.013 | ||
Met source | 0.032 | 0.159 | 0.117 | 0.636 | 0.653 | ||
main effect of the Met source | |||||||
dl-Met | 0.80b | 26.01 | 37.44 | 0.44 | 0.61 | ||
dl-Met-Met | 0.83a | 27.54 | 39.69 | 0.43 | 0.63 | ||
linear effect4 | |||||||
dl-Met | 0.003 | <0.001 | 0.013 | 0.111 | <0.001 | ||
dl-Met-Met | <0.001 | <0.001 | <0.001 | 0.068 | 0.027 | ||
quadratic effect4 | |||||||
dl-Met | 0.041 | 0.002 | 0.083 | 0.204 | 0.041 | ||
dl-Met-Met | 0.003 | 0.002 | 0.009 | 0.276 | 0.017 |
1 Values without the same small letters in the column indicate a significant difference (p < 0.05, n = 8). The data are presented as the mean ± standard error; 2 CAT: catalase; T-SOD: total superoxide dismutase; GSH-Px: glutathione peroxidase; T-AOC: total antioxidant capacity; MDA: malonaldehyde; 3 1: BD; 2: 0.15% dl-Met; 3: 0.30% dl-Met; 4: 0.45% dl-Met; 5: 0.60% dl-Met; 6: 0.15% dl-Met-Met; 7: 0.30% dl-Met-Met; 8: 0.45% dl-Met-Met; 9: 0.60% dl-Met-Met. (BD: basal diet; dl-Met: dl-methionine; dl-Met-Met: dl-methionyl- dl-methionine); 4 Trend analysis for BD and BD with 0.15%, 0.30%, 0.45% and 0.60% dl-Met or dl-Met-Met.